Detection of asymptomatic cardiac metastasis and successful salvage chemotherapy comprising a prednisone, etoposide, procarbazine, and cyclophosphamide regimen in an elderly japanese patient suffering from a delayed recurrence of diffuse large B-cell lymphoma

Keita Tagami, Shigeru Tanda, Hiroshi Kato, Atsushi Tashiro, Kenya Saji, Tatsuya Komaru, Muneo Tanida, Hiroshi Nakura, Kenichi Ishizawa

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

We report a case of facial diffuse large B-cell lymphoma (DLBCL) associated with recurrent metastasis in the heart and other sites in a 76-year-old Japanese woman. Initially, she developed DLBCL in her left upper eyelid that spread into the left orbit (Ann Arbor classification stage I). The lesion went into clinical regression after 4 cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy followed by radiotherapy. More than 3 years later, the lymphoma recurred in her facial skin, together with metastases in the mediastinal lymph nodes and the heart; the tumor in the heart was successfully detected by PET/CT and cardiac MRI. To treat the recurrent lesions, we performed a salvage chemotherapy regimen comprising prednisone, etoposide, procarbazine, and cyclophosphamide, which successfully induced tumor regression.

Original languageEnglish
Pages (from-to)62-68
Number of pages7
JournalCase Reports in Oncology
Volume5
Issue number1
DOIs
Publication statusPublished - 2012 Jan
Externally publishedYes

Keywords

  • Cardiac MRI
  • Cardiacmetastasis
  • Diffuse large B-cell lymphoma
  • Malignant lymphoma
  • PET/CT
  • Prednisone, etoposide,procarbazine, and cyclophosphamide regimen
  • Recurrence
  • Salvage chemotherapy

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Detection of asymptomatic cardiac metastasis and successful salvage chemotherapy comprising a prednisone, etoposide, procarbazine, and cyclophosphamide regimen in an elderly japanese patient suffering from a delayed recurrence of diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Cite this